Related Experiment Video
Updated: Aug 12, 2025
Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
ORIGANUM MAJORANA ATTENUATES CIPROFLOXACIN-INDUCED NEPHROPATHY IN RATS
Zainab Hussein1, Shaymaa Malik Yasir2
1DEPARTMENT OF PHARMACY, AL-ZAHRAWI UNIVERSITY COLLEGE, KARBALA, IRAQ.
Objective:
The aim: The researchers wanted to discover if Origanum majorana (O. M.) has any renoprotective qualities in a CIN rat model.
Patients And Methods:
Materials and methods: Control, ciprofloxacin (ciprofloxacin-induced CIN), two O. majorana groups (rats treated with O. majorana 30 mg and 45 mg), and two ciprofloxacin Plus O. majorana groups (n = 8) were randomly assigned to rats (CIN rats treated with O. majorana at 30 mg and 45 mg). Renal function tests were performed, as well as histological investigation.
Results:
Results: The levels of serum blood urea nitrogen (BUN) and creatinine increased after ciprofloxacin treatment. The serum BUN and creatinine levels in the ciprofloxacin + O. majorana groups were lower as well as in O. majorana groups, however, kidney damage was higher in the ciprofloxacin group and reduced tissue damage in combination groups and O. majorana groups rats.
Conclusion:
Conclusions: O. majorana decreases experimental CIN in vivo. This effect is thought to activate the antioxidant defenses pathway.
More Related Videos
06:46Author Spotlight: Understanding the Effect of Herbal-Cake-Separated Moxibustion in Rats with Renal Faliure
Published on: December 22, 2023
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
